SEC Company Response from ClearPoint Neuro, (CLPT) — Jan 20, 2026
ClearPoint Neuro, Inc.
Date: Jan. 20, 2026 · CIK: 0001285550 · Accession: 0001683168-26-000424
AI Filing Summary & Sentiment
File numbers found in text: 333-292733
Show Raw Text
CORRESP 1 filename1.htm CLEARPOINT NEURO, INC. 120 S. Sierra Ave., Suite 100 Solana Beach, California 92075 January 20, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Robert Augustin Re: ClearPoint Neuro, Inc. Registration Statement on Form S-3 Originally Filed January 14, 2026 File No. 333-292733 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), ClearPoint Neuro, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, January 22, 2026, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Please notify John Tishler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (858) 720-8943 as soon as possible as to the time the registration statement has been declared effective pursuant to this acceleration request. Very truly yours, CLEARPOINT NEURO, INC. By: /s/ Ellisa Cholapranee Name: Ellisa Cholapranee Title: General Counsel cc: John Tishler, Sheppard, Mullin, Richter & Hampton LLP